TRADERPERFORMANCECOACH

BionTech - Financial Health Excellent

做多
NASDAQ:BNTX   BioNTech SE
The Statistics say between $182-$253 (1 year)

This Looks like it can Happen in 1 Year.
That will depend on their Progress.


Let's see what will happen in 2023,
but it looks ok to hold for the next 5 Years or more


BioNTech aims to develop the first mRNA-based vaccine for Malaria
prevention with the initiation of a clinical trial by end of 2022
BioNTech is evaluating sustainable mRNA vaccine production capacities in Africa;
the Company’s efforts are supported by the joint convening powers of the World Health Organization (WHO)
and the Africa Centers for Disease Control and Prevention (Africa CDC)
BioNTech’s Malaria project is part of the ‘eradicate malaria’ initiative,
led by the kENUP Foundation, to accelerate the eradication of Malaria

Disclaimer:
Just my Idea! Find your Trading Ideas and learn and study more!

免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。